Top Social Impact Companies With Best Stability & Growth (5,116)

Investor Backing & Capital Strength: Capital raises and valuation step‑ups are prominent, including a $100M Series D in July 2024 at a reported $2.3B valuation to fund expansion into Medicare Advantage and Medicaid. Independent coverage and company materials corroborate the round and use of proceeds.

Market Expansion: Nationwide availability (all 50 states + D.C.) and moves into Medicare Advantage (targeted 51 markets by end‑2024) with Medicaid launches planned for 2025 broaden the addressable market. Company updates indicate these government lines are now active in select states.

Strategic Partnerships: Payer connectivity has accelerated from roughly 40 to 70+ plans with preferred‑network status at major carriers, and revenue scales with completed sessions rather than sign‑ups. These relationships underpin growing patient access and utilization.

Strong Revenue Growth: Revenue is described as on a multi‑year upswing through 2022, with external recognition on Deloitte’s Technology Fast 500 underscoring sustained momentum. Company communications in 2026 also cite being well over $100M in ARR, indicating material scale versus earlier periods.

Market Expansion: Footprint is portrayed as 3,500+ organizations across 150+ countries, supported by a 2024 London office opening and a larger Austin HQ in 2022. These moves align with indications of continued customer additions and international demand.

Innovation-Driven Growth: Product velocity includes 2026 launches of AI‑powered analytics and expanded AI‑driven social intelligence, plus a 2025 acquisition (Pyrra) and a Healix partnership to extend travel‑risk response. Leadership additions in May 2026 (including a Chief AI Officer) are framed as enabling continued growth via AI‑led strategy.

Strong Revenue Growth: Recent results show Hinge’s direct revenue up 28% year over year in Q1 2026, following a 39% rise in 2024 to $550.4 million and a further step-up to about $691 million in 2025.

Market Expansion: Expansion into Europe and Latin America is gaining traction, with international revenue reaching 31% of total in 2024 (up from 18%) and launches in Mexico and Brazil attaining the No. 2 download position by late 2025.

Resilient & Sustainable Growth: Trust and safety investments such as Face Check reduced interactions with bad actors by 20–30% with minimal revenue impact, supporting sustained engagement and monetization.

Investor Backing & Capital Strength: Significant late-stage financing, including an $88M Series C (April 2024) and a $150M Series D (March 2026) at a reported ~$3B valuation, is presented as fuel for continued scale. These rounds are explicitly tied to expanding product capabilities, the provider network, and payer/employer channels.

Strategic Partnerships: Expanded collaborations are highlighted, including a June 2026 research partnership with Stanford and broad access via 125+ insurer relationships, with added employer and health‑system programs (e.g., EAP‑to‑insurance continuity, Amazon, Circle Medical). These linkages signal deeper distribution and credibility across stakeholders.

Market Expansion: Operational reach appears to be widening through national payer coverage (including Medicare/Medicaid), employer routes, and health‑system integrations alongside a provider network cited around 26,000. Utilization markers such as 7M visits in 2025 and active hiring/office expansion indicate scaling across markets.

Strong Revenue Growth: Revenue reached record levels in 2025 and again in Q1 2026. Management increased 2026 guidance to about $650–$675M, signaling continued top-line growth.

Profitability: GAAP net income hit a company record in 2025 and rose sharply year over year to $54.0M in Q1 2026. The company also reported record adjusted net income for full‑year 2025.

Market Expansion: A definitive agreement to acquire BNCCORP (BNC National Bank) positions the company to become a bank holding company, enabling geographic expansion and product diversification. The move is also intended to reduce reliance on third‑party bank partners.

Investor Backing & Capital Strength: Recent financing includes a June 2024 seed and an October 2025 $15.5M Series A led by Costanoa with Town Hall Ventures and Khosla, positioned to fund hiring, product, and market expansion. Public investor and media materials describe this capital as intended to scale operations and partnerships.

Market Expansion: Operations are described as growing beyond New York into New Jersey and Ohio, with compliance entities in multiple states and localized, multilingual school pages signaling multi‑district deployment. District approvals and company updates point to a widening on‑the‑ground footprint.

Strategic Partnerships: Public district materials (e.g., Millville Public Schools and Upper Deerfield Township in NJ) announce Marble programs, indicating active school partnerships. Company communications highlight a school‑centered model built specifically for schools, reinforcing this partnership‑led growth.

Market Expansion: Operations are described across numerous U.S. cities and key European hubs (Dublin, Paris, London, Berlin), indicating a broadened geographic footprint beyond a single‑market provider. Materials also reference global pickup capability across regions, signaling scale beyond a local service.

Product Line Growth: Recent updates highlight expanded Device Retrievals to cover more device types and packaging options. A software‑enabled lifecycle platform with a SaaS app, API, and unified data model points to ongoing broadening of the offering.

Strategic Partnerships: Enterprise logos and customer mentions (e.g., Instacart, Lyft, Qualtrics, X) and a California public‑sector pilot indicate embedded institutional relationships. Third‑party materials such as an ESG report from Ping Identity also reference active programs tied to Revivn.

Market Expansion: New full-service branches in Boston Seaport, Andover, and Falmouth are slated for 2026—its first branch additions since 2010, with OCC filings submitted in December 2025. This signals deliberate footprint growth in core Massachusetts markets.

Strong Market Position & Advantage: Independent trade press places the bank as the top bank lender for Massachusetts single‑family mortgages in 2025 by both dollar volume and number of loans. This reflects organic strength in its flagship residential franchise.

Resilient & Sustainable Growth: Assets expanded from roughly $1.6 billion five years ago to over $5.0 billion by early 2026, alongside an explicitly organic growth plan. Disclosures also note capital ratios well in excess of regulatory minimums, supporting prudent scaling.

Strong Hiring & Retention: Active recruiting is evident with 20+ open roles on Indeed across multiple states and functions, alongside a LinkedIn size band of 51–200 and recent activity signaling team buildout. Role postings span therapists, a remote RN health advocate, and operations/partnerships positions, indicating capacity expansion.

Market Expansion: Medicare-covered virtual therapy is marketed across all 50 states with state-by-state pages and booking via channels like Zocdoc, pointing to an enlarging go-to-market footprint. Site and blog updates through 2025–2026 and a market-launch role (e.g., Philadelphia) further support ongoing geographic growth.

Strategic Partnerships: A publicly announced collaboration with Advanced Nursing & Home Care and recent LinkedIn partnership/event posts suggest growing referral networks. These signals align with efforts to embed within senior-care ecosystems to broaden distribution.

Investor Backing & Capital Strength: Recent funding activity—including a reported portion of a $30M+ round in July 2026 alongside a $28.1M Series B in 2023—signals strengthened runway to support operations and selective scaling. This momentum points to renewed capacity to invest in growth after a difficult 2025.

Market Expansion: A multi-state footprint with launches and active operations across Florida, Michigan, Ohio, Virginia, and Washington reflects continued geographic reach. Active job postings and partner-facing materials further indicate ongoing expansion activity aimed at Medicaid/Medicare populations with SMI.

Strategic Partnerships: Payer-facing positioning and reported collaborations with large platforms (e.g., Carelon Behavioral Health) show ongoing engagement with Medicaid managed care organizations. These arrangements suggest continued commercial traction in value-based models for SMI populations.

Investor Backing & Capital Strength: Audited 2025 statements show total assets rising from roughly $1.11B to $1.19B and net assets increasing to about $1.06B, supported by strong investment returns—providing runway for growth initiatives. A $100M social bond (2021) and an active Strategic Impact Fund with $118M deployed over four years signal substantial capacity to finance expansion.

Product Line Growth: On June 16, 2026, Britebound announced the acquisition of Lab4U, adding a hands‑on STEM learning platform to its digital ecosystem and expanding offerings. Rebranding and ongoing platform activity (e.g., Futurescape, Future Network, GoZig) indicate a broader, evolving product suite.

Market Expansion: The organization reports reaching 15M+ young people annually via digital experiences while increasing programmatic throughput through grants and impact investments. The January 2026 rebrand from American Student Assistance to Britebound signals a wider mandate and national presence.

Market Expansion: District coverage is described as rising from more than 1,000 in 2021 to 1,900+ by 2026, reaching 2.5 million students across 26,000+ schools. Recent district documents and case studies note fresh implementations and active use, reinforcing continued penetration.

Product Line Growth: The 2026 launch of Ellevation Benchmark as part of a unified ELD solution adds benchmark assessments alongside data, workflows, and instructional supports. Ongoing releases and integrations with assessment ecosystems (e.g., WIDA, NWEA, i‑Ready) indicate active investment and a widening suite.

Investor Backing & Capital Strength: Operation within Curriculum Associates since the 2021 acquisition provides resources and distribution that support customer and product growth. Current postings for senior engineering and product design roles in 2026 further signal capacity to invest.

Investor Backing & Capital Strength: A March 2026 investment of approximately $250 million from TPG’s The Rise Funds is described as capital to accelerate growth, expand the national network, and invest in technology. This sizeable backing signals runway to scale operations and product capabilities.

Strategic Partnerships: New 2025–2026 integrations with Manifest MedEx under California’s Data Exchange Framework and behavioral health collaborations (e.g., SimplePractice, MiResource) extend the platform’s reach into clinical and behavioral workflows. State and enterprise collaborations (e.g., TennCare and Cone Health use cases) show embedded Findhelp-powered workflows and active usage.

Market Expansion: State materials describe tens of thousands of completed social-needs assessments and active staff usage, and Maine cites more than 650 customers with 172,000 residents completing 742,000 searches on the platform. Company materials list 970k+ verified program locations and an active 2026 events cadence, indicating continued footprint growth.

Innovation-Driven Growth: Launches such as the Integrations Marketplace (January 2026) with ongoing updates, along with new capabilities like Beaker and the Action Center, signal sustained product velocity through 2026. These additions aim to speed hiring and broaden connectivity across HR stacks.

Strategic Partnerships: An enhanced integration with Indeed and Gold ATS Partner status (June 2026), plus alliances with AHLA and payroll/HCM partners like UKG and Viventium, expand distribution and solution reach. These ecosystem moves are positioned to widen the top of funnel and deepen adoption in core verticals.

Strong Market Position & Advantage: Multiple G2 Leader badges in Spring/Summer 2026 and continued designation as AHLA’s Leadership Partner underscore visibility and traction in target segments. Auto OEM and dealer-network programs further reinforce category strength in retail automotive.

Strong Revenue Growth: ARR is estimated to have surpassed $200M by May 2024 with roughly 27% year over year growth, indicating ongoing top-line expansion. While slower than pre-2022 hypergrowth, this still reflects material scaling at enterprise revenue levels.

Market Expansion: The company reports welcoming 240 new customers in 2024 and now powers over 1,300 biotechnology companies. This evidences continued penetration and up-market traction in life-sciences R&D.

Product Line Growth: New modules and AI capabilities launched in 2024, including Benchling Bioprocess and analytics features, broadened the platform beyond research into development and data analysis. The PipeBio acquisition further strengthened high-throughput biologics and AI-assisted discovery.

Strong Revenue Growth: External recognition on the 2025 Inc. 5000 and company statements of continued annual revenue increases indicate sustained momentum.

Market Expansion: A new Austin office in 2026, headcount growth over recent years, and hiring plans into 2027 reflect scaling capacity and geography alongside newly announced institutional partners.

Strategic Partnerships: State and system engagements—such as a funded New Jersey contract, Florida legislative references, and added university collaborations—signal deepening institutional and statewide ties.

Innovation-Driven Growth: The rollout of VelocityAI and AI "PSIF Insights" on the Accelerate platform in 2025–2026 points to active R&D and ongoing feature expansion. Independent analyst and award recognition align with this momentum around AI-enabled capabilities.

Strong Market Position & Advantage: Leader placement in Verdantix’s Green Quadrant and a #6 rank in G2’s 2026 Best Software Awards indicate durable competitive standing and broad market visibility. Multiple 2026 recognitions further underscore prominence in the EHS software segment.

Product Line Growth: The January 2024 acquisition of Contractor Compliance broadened contractor and permit management capabilities, expanding the platform’s scope. Ongoing module enhancements (e.g., Incident Management updates) add more use cases across EHS/ESG.

Profitability: 2025 marked Udemy’s first full year of positive net income, with adjusted EBITDA rising to about $95 million and margins expanding. These results reflect healthier unit economics alongside the subscription mix shift.

Cost & Operational Efficiency: Gross margin improved from 63% in 2024 to 66% in 2025, helped by growing subscriptions and a reduced instructor revenue share on subscriptions (cut to 15% in 2026). The trend points to better content cost leverage and operating discipline.

Strategic Partnerships: Multiple AI and certification-focused launches and integrations with AWS, Microsoft, Google, and OpenAI indicate continued product investment aimed at enterprise skills. These partnerships broaden reach and reinforce the enterprise skills roadmap.

Future-Ready Strategy: Modernization initiatives—digital transformation, process standardization, and facilities upgrades—are emphasized alongside new system-level responsibilities such as leading the Credit Risk Management Support Office. These steps signal deliberate capability building to meet evolving operational and risk-management demands.

Innovation-Driven Growth: Payments and data initiatives are prominent, with the Chicago Payments Symposium, FedNow support, and the production of widely used indicators (CFNAI, NFCI). These activities point to an innovation-driven agenda that extends the Bank’s impact beyond its district.

Strong Hiring & Retention: Planned staffing for 2025 is higher than 2024 actuals, and development programs such as hosting the largest-ever Year Up cohort indicate active talent investment. Although hiring undershot plan in 2024, budgets show intent to expand capacity in the near term.

Market Expansion: Geographic reach has broadened to about 25 U.S. states for Care+ in‑home preventive visits, with coverage spanning Medicare, Medicaid, and Marketplace lines of business. Materials from 2023–2026 indicate a step‑up from 5 states to roughly half the nation by February 2026.

Strategic Partnerships: Collaborations with payers and providers are expanding, exemplified by Blue Cross Blue Shield of Michigan/Blue Care Network offering in‑home diabetic retinal screenings starting April 1, 2026 and UCI Health signaling plans to grow joint programs. Additional references highlight added payer/provider relationships through 2025–2026.

Investor Backing & Capital Strength: A $55 million Series B closed on May 15, 2025 led by General Catalyst with participation from a16z Bio + Health and others, providing fuel to scale at‑home services. Third‑party trackers and coverage cite total funding in the roughly $92.6 million to ~$125 million range.